Abstract:Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of unknown etiology that affects the central nervous system and can lead to neurological impairment. Our aim was to determine whether MS patients also show inflammatory changes in the oral cavity more frequently than healthy individuals. For this purpose, we examined plaque samples for various mediators and their correlation with clinical findings. A study group (MS) and a control group were examined and compared. The plaque samples were analyzed for the expression of interleukins (IL-2, -6, -10), matrix metalloproteinases (MMP-7, MMP-9), and a surface antigen CD90 by quantitative real-time PCR. The clinical parameters examined were the Mombelli plaque index; bleeding on probing (BOP) index; periodontal pocket depth; and decayed, missing, and filled tooth (DMFT) index. The expression of MMP9 was significantly (p = 0.035) higher in the control group. The expression of IL-2 was increased four-fold in the MS group; however, this difference was not statistically significant. The mean PD (p < 0.001) and BOP index (p = 0.029) values were increased in the study group. The clinical parameters of the BOP index and PD were significantly amplified in the MS patients. However, no causal relationship between the investigated inflammatory mediators and the clinical findings could be established in this case series.

Correction: Fehlhofer et al. Expression of Inflammatory Mediators in Biofilm Samples and Clinical Association in Multiple Sclerosis Patients in Remission—A Pilot Study. Life 2024, 14, 367

Expression of Inflammatory Mediators in Biofilm Samples and Clinical Association in Multiple Sclerosis Patients in Remission—A Pilot Study

Publisher Correction: LifeTime and Improving European Healthcare Through Cell-Based Interceptive Medicine

Erratum: Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy

Correction: Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis

Correction: Predatory journals: Perception, impact and use of Beall's list by the scientific community–A bibliometric big data study

Correction: Ulman-Macón et al. Morphological Changes of the Suboccipital Musculature in Women with Myofascial Temporomandibular Pain: A Case-Control Study. Life 2023, 13, 1159

Author Correction: Smoking Induces DNA Methylation Changes in Multiple Sclerosis Patients with Exposure-Response Relationship

Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. Molecules 2021, 26, 866

WITHDRAWN: The Atlas of Inflammation Resolution (AIR)

Corrigendum to 'Spatial enrichment of the type 1 interferon signature in the brain of a neuropsychiatric lupus murine model 114, 511-522]

Correction: Social Media Use and Its Concurrent and Subsequent Relation to a Biological Marker of Inflammation: Short-Term Longitudinal Study

Correction: Ren et al. Exercise for Mental Well-Being: Exploring Neurobiological Advances and Intervention Effects in Depression. Life 2023, 13, 1505

Corrigendum: Study protocol for FIBROKIT: a new tool for fibromyalgia diagnosis and patient follow-up

[Corrigendum] Role of cysteine‐rich angiogenic inducer 61 in fibroblast‐like synovial cell proliferation and invasion in rheumatoid arthritis

Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens 2023, 12, 703

[Retracted] A disintegrin and metallproteinase 15 knockout decreases migration of fibroblast‐like synoviocytes and inflammation in rheumatoid arthritis

Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis

Correction to: Cystic Fibrosis Revisited - A Review Study

Retraction Note: Study on the expression and mechanism of inflammatory factors in the brain of rats with cerebral vasospasm